Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo

被引:21
|
作者
Carome, MA
Kang, YH
Bohen, EM
Nicholson, DE
Carr, FE
Kiandoli, LC
Brummel, SE
Yuan, CM
机构
[1] WALTER REED ARMY MED CTR,SERV NEPHROL,WASHINGTON,DC 20307
[2] WALTER REED ARMY MED CTR,DEPT MED,ENDOCRINE SERV,WASHINGTON,DC 20307
[3] USN,MED RES INST,DIV PATHOL,BETHESDA,MD
来源
NEPHRON | 1997年 / 75卷 / 01期
关键词
phosphorothioate oligonucleotide; antisense; rat kidney; gene therapy; autoradiography;
D O I
10.1159/000189504
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Previous animal studies have demonstrated that following systemic administration phosphorothioate oligodeoxynucleotides (S-ODNs) are primarily excreted by the kidneys and that renal tissue levels of S-ODNs exceed that of other organs, Thus, the kidney may be an ideal target organ for application of antisense S-ODNs in vivo, We examined which cells within the rat kidney have uptake of radiolabeled S-ODNs following intravenous infusion. A 20-base S-35-ODN was infused into 6 adult male Wistar rats. Three animals each were sacrificed 30 min and 4 h after infusion. The kidneys were then removed, fixed, and tissue autoradiography was performed. Similar results were obtained in both groups, The highest level of radioactivity was seen within the proximal tubules. Lower levels of activity were seen within the glomerulus, the parietal epithelial cells of Bowman's space, and distal tubular cells, Very weak activity was also detected within the cells of the loop of Henle and the medullary collecting ducts. These results demonstrated that within the kidney S-ODNs were taken up primarily by proximal tubular cells, with much lower uptake by cells in other segments of the nephron.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 50 条
  • [31] Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo
    Kitajima, I
    Unoki, K
    Maruyama, I
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (02): : 233 - 239
  • [32] TISSUE DISTRIBUTION AND SELECTIVE KIDNEY UPTAKE OF TRITIATED AMINOGLYCOSIDES IN RAT
    EZER, J
    MAHON, WA
    INABA, T
    PHARMACOLOGIST, 1976, 18 (02): : 206 - 206
  • [33] NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO
    BOSTOM, A
    BROSNAN, JT
    HALL, B
    NADEAU, MR
    SELHUB, J
    ATHEROSCLEROSIS, 1995, 116 (01) : 59 - 62
  • [34] CATIONIC LIPIDS ENHANCE CELLULAR UPTAKE AND ACTIVITY OF PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDES
    BENNETT, CF
    CHIANG, MY
    CHAN, HD
    SHOEMAKER, JEE
    MIRABELLI, CK
    MOLECULAR PHARMACOLOGY, 1992, 41 (06) : 1023 - 1033
  • [35] Cellular distribution of cytochromes P-450 in the rat kidney
    Cummings, BS
    Zangar, RC
    Novak, RF
    Lash, LH
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (04) : 542 - 548
  • [36] Cellular uptake of phosphorothioate oligonucleotide facilitated by cationic porphyrin:: A microfluorescence study
    Kocisová, E
    Praus, P
    Mojzes, P
    Sureau, F
    Stepánek, J
    Seksek, O
    Turpin, RY
    BIOPOLYMERS, 2006, 82 (04) : 325 - 328
  • [37] In vivo delivery of antisense oligodeoxynucleotides into rat Kupffer cells
    Ponnappa, BC
    Dey, I
    Tu, GC
    Zhou, F
    Garver, E
    Cao, QN
    Israel, Y
    JOURNAL OF LIPOSOME RESEARCH, 1998, 8 (04) : 521 - 535
  • [38] Modulation of cellular uptake and biological activities of oligodeoxynucleotides using galactose derivatives
    Ishihara, H
    Nakamoto, T
    Sasaki, A
    Ikeda, M
    Kawaguchi, T
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 903 - 904
  • [39] In vivo inhibition of hepatitis B virus replication and gene expression by targeted phosphorothioate modified antisense oligodeoxynucleotides
    钟森
    郑素军
    陈枫
    张建军
    邓存良
    温守明
    王升启
    中华肝脏病杂志, 2002, (04) : 44 - 47
  • [40] In vivo inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides in athymic nude mice
    Yao, ZQ
    Zhou, YX
    Feng, XM
    Chen, CX
    Guo, J
    JOURNAL OF VIRAL HEPATITIS, 1996, 3 (01) : 19 - 22